Tampa General Hospital Cancer Institute Hosts Global Symposium on Microbes, Genes, and Cancer
Event summary
- Tampa General Hospital Cancer Institute and USF Health Morsani College of Medicine will host the 'Microbes, Genes & Cancer' Symposium on March 2-3, 2026.
- The symposium will bring together international cancer research leaders to discuss the intersection of microbes, genetics, and immune pathways in cancer development and treatment.
- A special session will commemorate the 50th anniversary of the discovery of interleukin-2 (IL-2), featuring prominent speakers from the National Academy of Sciences and Medicine.
- The event is part of International Science Innovation Week, combining with the Global Virus Network Scientific Meeting from March 4-6, 2026.
The big picture
The symposium highlights the growing recognition of the role of microbes, genetics, and immune responses in cancer risk and treatment outcomes. This event underscores the strategic importance of interdisciplinary collaboration in advancing cancer research and therapy. The participation of world-renowned experts and the commemoration of the IL-2 discovery further emphasize the symposium's significance in the field of oncology.
What we're watching
- Research Collaboration
- The pace at which new collaborations emerge from the symposium could accelerate advancements in cancer treatment.
- Immunotherapy Breakthroughs
- How the latest breakthroughs in cancer biology, microbiome, and immunotherapy will impact future treatment strategies.
- Industry Leadership
- Whether Tampa General Hospital Cancer Institute can sustain its position as a leader in cancer research and treatment.
Related topics